AbbVie Total Non-Operating Income/Expense 2012-2026 | ABBV
AbbVie total non-operating income/expense for the twelve months ending March 31, 2026 was $-9.357B, a 45.07% increase year-over-year.
- AbbVie annual total non-operating income/expense for 2025 was $-8.362B, a 54.25% increase from 2024.
- AbbVie annual total non-operating income/expense for 2024 was $-5.421B, a 16.69% decline from 2023.
- AbbVie annual total non-operating income/expense for 2023 was $-6.507B, a 40.24% increase from 2022.